ADC Drug Conjugate Market Hits $42.55B Forecast by 2035
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
The move reflects a wider trend of refrigerated dip brands leveraging recipe-driven merchandising to boost basket size …
The CE Mark clearance positions Valvosoft within Europe's growing cardiac therapeutics market as the company accelerate…
Wildfire particulate exposure is emerging as a functional-foods category trigger, with brands eyeing lung-support and a…
Merzenich's neuroplasticity framework is foundational to the fast-growing cognitive supplement and digital therapeutics…
No ingredient, clinical data, formulation, regulatory filing, or food-and-beverage company is present in the source mat…
The collaboration targets care-gap closure in OSA management, a condition increasingly addressed by sleep-support nutra…
The IND application completed its 30-day FDA review without a clinical hold, opening U.S. patient enrollment for the an…
The 30-day FDA review with no clinical hold signals a clear regulatory path forward for the IL-1α–targeting monoclonal …
The V-SPINE study opens U.S. enrollment for a condition with significant unmet need, signaling continued biotech intere…
Submission does not meet Functional News editorial scope. No ingredient, clinical endpoint, structure-function claim, o…
The stevia-free, still-format launch positions coconut water as a functional gut-health vehicle in a crowded better-for…